American Cancer Society names Aflac 2025 Corporate Partner of the Year

Rhea-AI Summary

Aflac (NYSE:AFL) was named the American Cancer Society’s 2025 Corporate Partner of the Year on April 23, 2026, recognizing a multimillion-dollar, multiyear partnership that advances fundraising, screenings, workplace wellness and national advocacy. Aflac launched the Check for Cancer movement in 2025 to boost screening awareness and utilization.

Positive

• Multimillion-dollar, multiyear partnership with American Cancer Society announced
• Launched Check for Cancer movement in 2025 to increase screening awareness
• Recognition as 2025 Corporate Partner of the Year for measurable partnership impact

Negative

• None.

News Market Reaction – AFL

+0.32%

+0.32% Session close to close

In the Apr 23 session, AFL gained 0.32%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights AFL’s recognition by the American Cancer Society as its 2025 Corporate ...

Analysis

This announcement highlights AFL’s recognition by the American Cancer Society as its 2025 Corporate Partner of the Year, reflecting a multiyear collaboration focused on awareness and use of cancer screenings. The article cites survey data showing 90% of Americans have delayed checkups, underscoring the health gap AFL targets through its Check for Cancer movement. In recent months, the company has combined brand, ethics, product and capital allocation updates, so investors may track how such initiatives support long-term positioning.

Key Figures

Delayed checkups: 90% of Americans

1 metrics

Delayed checkups 90% of Americans 2025 Aflac Wellness Matters Survey on delayed health checkups and screenings

Historical Context

5 past events · Latest: Apr 02 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 02	Earnings date notice	Neutral	-0.2%	Set timing for Q1 2026 results release and management webcast.
Mar 31	Reinsurance transaction	Positive	+1.4%	First external-party reinsurance deal with Japan Post Insurance via coinsurance.
Mar 23	Product launch	Positive	+0.4%	Introduced new long-term care rider for Group Life Term to 120 product.
Mar 18	Ethics recognition	Positive	-1.5%	Named a World’s Most Ethical Company for 20th consecutive year.
Feb 04	Earnings & dividend	Positive	+3.4%	Reported Q4 2025 results, reiterated dividend increase and highlighted buybacks.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Over recent months, AFL’s stock usually moved in the same direction as the qualitative tone of news, with only one notable divergence on a positive ethics recognition.

Recent Company History

Recent news for AFL has focused on capital returns, ethics recognition, product innovation and reinsurance expansion. On Feb 4, 2026, AFL reported Q4 2025 results with $1.4 billion in net earnings, a $0.61 Q1 2026 dividend and $800 million in buybacks, which saw shares rise. Subsequent announcements included being named a World’s Most Ethical Company and launching a new long-term care rider. Today’s American Cancer Society partnership award fits this pattern of brand, ethics and community-focused recognition.

Key Terms

cancer screenings

1 terms

cancer screenings medical

"a significant focus on awareness and utilization of cancer screenings."

Cancer screenings are routine medical tests or check-ups designed to find signs of cancer before symptoms appear, using methods like imaging, blood tests, or tissue sampling. For investors, screening programs are important because they drive demand for diagnostic products and services, affect regulatory approvals and reimbursement for new tests, and can change the size and timing of treatment markets by catching disease earlier—like finding a small leak before it becomes a major repair.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Award recognizes Aflac for demonstrating exceptional partnership, delivering meaningful impact in advancing shared lifesaving mission

COLUMBUS, Ga., April 23, 2026 /PRNewswire/ -- Aflac Incorporated, the leading provider of supplemental health insurance in the U.S., announced today that the American Cancer Society has named the company it's 2025 Corporate Partner of the Year. The annual recognition honors a company that has demonstrated an exceptional partnership with the American Cancer Society (ACS), driving significant advancements in fundraising, educational initiatives, workplace wellness and national advocacy.

"Aflac exemplifies what is possible when a corporate partner fully aligns its purpose, leadership and resources with our mission," said Shane Jacobson, Chief Executive Officer of the American Cancer Society. "Through a multimillion–dollar commitment and hands–on leadership engagement, Aflac has set a gold standard for corporate leadership in the fight against cancer, advancing lifesaving research, expanding access to care and strengthening support for patients and families nationwide. We are honored to recognize Aflac as our 2025 Corporate Partner of the Year and grateful for the measurable, lasting impact this partnership continues to deliver."

In 2025, Aflac entered a multiyear partnership with ACS to further its commitment to support and advance cancer care, with a significant focus on awareness and utilization of cancer screenings. According to the 2025 Aflac Wellness Matters Survey®, 90% of Americans have delayed health checkups and screenings that could help save their lives,¹ in spite of ACS data that says for many types of cancer, early detection can significantly increase survival rates.²

"As a leading provider of cancer insurance in the United States, we see firsthand how families are impacted physically, emotionally and financially by cancer every year, which makes this prestigious recognition from the American Cancer Society even more gratifying," said Virgil Miller, president, Aflac Incorporated and Aflac U.S., and chair of the Georgia ACS CEOs Against Cancer chapter. "Aflac understands the value of investing in the promise of cancer advocacy, and we appreciate the power of working so closely with the ACS, the leading cancer-fighting organization in the nation. We are extremely proud to receive this honor."

Through its Check for Cancer movement, initiated in 2025, Aflac has turned the everyday checkered pattern seen on clothing, furniture and more, into a powerful reminder to check for cancer. The company strives to increase cancer screenings, supporting ACS's mission to improve the lives of people with cancer and their families through advocacy, research and patient support, ensuring everyone has an opportunity to prevent, detect, treat and survive cancer.

Learn more about Aflac's partnership with the American Cancer Society at Cancer.org/Aflac.

ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.³ The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 20 consecutive years (2026) and Fortune's World's Most Admired Companies for 25 years (2026). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."

¹Aflac. "2025 Wellness Matters Survey Overview^®." https://www.aflac.com/docs/cancer-campaign-wellness-matters/aflac-wellness-matters-survey.pdf. Accessed March 24, 2025.

²https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf

³LIMRA 2024 U.S. Supplemental Health Insurance Total Market Report Accessed March 24, 2025.

Media contact: Jon Sullivan, 706-763-4813 or jsullivan@aflac.com
Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or dyoung@aflac.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/american-cancer-society-names-aflac-2025-corporate-partner-of-the-year-302751198.html

SOURCE Aflac

FAQ

Why did the American Cancer Society name Aflac (AFL) its 2025 Corporate Partner of the Year?

Because Aflac committed multimillion-dollar support and active leadership to ACS initiatives. According to Aflac, the award recognizes fundraising, educational initiatives, workplace wellness and national advocacy driven by their multiyear partnership.

What is Aflac’s Check for Cancer movement and when did Aflac start it?

Check for Cancer is a public-awareness initiative started by Aflac in 2025 to encourage screenings. According to Aflac, it uses the company’s checkered motif to remind people to get screenings and to increase early detection rates.

How does Aflac’s partnership with ACS aim to improve cancer outcomes for patients?

By funding research, expanding access to screenings and supporting patient services through coordinated programs. According to Aflac, the multiyear commitment focuses on awareness, utilization of screenings and strengthening patient and family support systems.

Does Aflac’s 2025 recognition affect its product offerings or insurance coverage?

The announcement does not change Aflac’s insurance products or coverage terms. According to Aflac, the recognition reflects corporate partnership and advocacy efforts rather than alterations to policy features or benefits.

Where can investors learn more about Aflac’s partnership with the American Cancer Society (AFL)?

Investors can find details about the partnership and initiatives at the ACS Aflac web page. According to Aflac, more information is available at Cancer.org/Aflac, including the Check for Cancer movement and partnership highlights.